Infant follow-up postdelivery from a hepatitis C viral load positive mother

Craig V Towers1, Kimberly B Fortner1

  • 1a Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine , University of Tennessee Medical Center , Knoxville , TN , USA.

Insights

Hepatitis C virus (HCV) antibody screening for infants born to HCV-positive mothers shows low follow-up rates, with less than half completing the recommended 18-month evaluation. Alternative screening strategies are needed.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection poses risks to newborns from infected mothers.
  • Current guidelines recommend infant antibody testing at 18 months post-delivery for maternal HCV.
  • Compliance with these recommendations is crucial for early detection and management.

Purpose of the Study:

  • To assess adherence to the 18-month infant follow-up screening for Hepatitis C virus (HCV).
  • To analyze the rates of infant follow-up for deliveries from mothers with a positive HCV viral load.
  • To identify barriers to infant follow-up care in this specific cohort.

Main Methods:

  • Prospective database established for pregnancies with maternal HCV viral load positivity.
  • Infant follow-up data collected for deliveries between January 2015 and June 2016.
  • Simple percentages and Poisson binomial 95% confidence intervals used for statistical analysis.

Main Results:

  • 127 infants were born to mothers with positive HCV viral load.
  • Only 55 infants (43%) completed recommended pediatric appointments and remained in follow-up.
  • A significant proportion (57%) were lost to follow-up, with many attending only initial visits.

Conclusions:

  • Infant follow-up for Hepatitis C virus (HCV) screening at 18 months is achieved in less than half of cases.
  • Current follow-up protocols demonstrate low compliance rates.
  • Development and evaluation of alternative infant HCV screening strategies are urgently required.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.8K
Position-effect Variegation02:32

Position-effect Variegation

In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
7.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324